- -Trxade Group Inc. is a supplies and services innovator for the pharmaceutical industry, working to keep small retailers competitive with large chains and costs accessible for end-use patients
- -Trxade Group has seen its brand grow significantly during the past year, adding a 244 percent year-over-year increase to its quarterly revenues during the spring
- -The company will further draw attention to its profile by joining other brand presentations at the LD 500 Virtual Investor Conference scheduled to begin Sept. 1 and run through the week
- -The LD 500 conference is designed to provide an online-accessible meeting of small cap companies and potential investors even during the ongoing global pandemic, and it is open to everyone
Trxade Group (NASDAQ: MEDS) will introduce a raft of potential new investors to the accomplishments of its growing brand in the medical technology space when CEO Suren Ajjarapu makes a 20-minute presentation on the company as part of the upcoming LD 500 Virtual Investor Conference.
Ajjarapu will also interact more directly with sanctioned LD 500 patrons who are curated through the event’s network, holding one-on-one interviews with potential investors during the hours surrounding his 1:40 p.m. EST presentation on Wednesday, Sept. 2 (http://ibn.fm/nlt6c).
The LD 500 conference is designed to attract hundreds of leading names in the microcap markets space as well as potential sources of capital for the companies. The convention and conference industry has been battered by the distancing demands of the novel coronavirus pandemic but LD 500 organizers have adapted with their most ambitious gathering to date — up to 500 companies and tens of thousands of participants registered for the four-day virtual investor summit that begins Sept. 1, with pre-event activities slated this coming Monday, Aug. 31 (http://ibn.fm/U9diD).
Trxade Group has been building its B2B platform into a B2C-friendly portfolio that helps independent local pharmacies compete with large-scale retail chains through drug pricing transparency and network strength, also helping health patients to gain telemedicine access to physicians’ clinics without leaving home, and to have prescriptions ordered online and delivered to the home (http://ibn.fm/9zSca).
Trxade Group’s platform also provides assistance with buying personal protective equipment (“PPE”) for businesses challenged by the ongoing global pandemic and the wellness needs of employees carrying out company assignments.
“This platform resolves a fundamental trust problem impacting employer’s safety and security policies, allowing companies to more effectively combat COVID-19 concerns in the workplace,” Bonum Health President Ashton Maaraba stated. Bonum Health is a subsidiary of Trxade Group.
Trxade’s flagship operation has achieved more than 50 percent penetration of its intended market, the 22,000 independent pharmacies across the United States that serve their communities with features not too far removed from the corner drugstore days of the past century.
“We believe this radical price transparency, economy of scale and competition amongst suppliers leads (to) up to 10% reduction in pharmacies’ total annual drug purchase costs, with a drug-level savings of up to 90% on certain pharmaceutical products,” Ajjarapu said in a recent earnings conference call (http://ibn.fm/zc0Wf).
Trxade Group reported those Q2 financial results in July, noting the company’s revenues had grown by 244 percent year-over-year for the quarter, and by 199 percent sequentially from the first quarter of the year.
For more information, visit the company’s website at www.TrxadeGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
